Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
In the context of the global spread of the new coronavirus infection, studies aimed at investigating formation of anti-infectious and post-vaccination immunity are of special importance, which is necessary to prevent and reduce morbidity and mortality due to SARS-CoV-2 infection.Purpose: to assess anti-infectious immunity against SARS-COV-2 in various forms of the disease and development of post-vaccination humoral reactions in medical workers of the perinatal center. Materials and methods. A study of blood serum was carried out to assess SARS-CoV-2-specific IgM and IgG antibodies in 119 medical workers recovered after COVID-19, divided into groups based on the disease severity (mild, moderate and asymptomatic), as well as in 62 vaccinated employees, divided into groups according to age. Semi-quantitative measurement of virus-specific antibodies was carried out by ELISA with test systems "SARS-COV-2-IgG-ELISA-BEST" and "SARS-COV-2-IgM-ELISA-BEST".Statistical processing of the research results was carried out using Microsoft Excel 2010 and Statistica 6. Quantitative characteristics were presented as median (ME), lower and upper quartiles (LQ1-UQ3); qualitative parameters – as absolute value and relative number (%). Difference between groups was analyzed by using the χ2 test (qualitative) and the Mann-Whitney U-test (quantitative).Results. The results of the study showed that the majority of employees with a moderate-severe form of SARS-COV-2 had a high level of IgG (PR - a positivity rate of more than 9.0 arbitrary units) 9 months after the disease compared to those who suffered from mild or asymptomatic (83.3% versus 25.8% and 13.3%, p 0.017) infection. The duration of IgG circulation after former illness had no relation to its severity and patient age. The effectiveness of the primary vaccination "Sputnik V" and revaccination with "Sputnik Light" and "KoviVak" was 100% after inoculating the vaccine second component. The lowest level of antibodies after the first vaccination is recorded in persons over 60 years old (1.48 (1.12-3.25 versus PR = 8.48 (5.78-10.11) and 9.27 (5.84-10, 31) arbitrary units, p 0.017)), in comparison with young and middle-age subjects. The speed SARS-COV-2 elimination of IgG at 6, 9 or more months after vaccination depends on relevant initial peak antibody concentration. Subjects who were initially vaccinated with the KoviVac vaccine, IgG was not detected 2 months after vaccination. The protective effect of "Sputnik V", "Sputnik Light", "KoviVac" after re-infection with SARS-COV-2 averages 71.2%. Conclusion. Thus, the results obtained on assessing anti-infectious and post-vaccination immunity against SARS-CoV-2 emphasize the need for further studies on a larger patient cohort, especially in those with asymptomatic infection as well as the elderly subjects.
In the context of the global spread of the new coronavirus infection, studies aimed at investigating formation of anti-infectious and post-vaccination immunity are of special importance, which is necessary to prevent and reduce morbidity and mortality due to SARS-CoV-2 infection.Purpose: to assess anti-infectious immunity against SARS-COV-2 in various forms of the disease and development of post-vaccination humoral reactions in medical workers of the perinatal center. Materials and methods. A study of blood serum was carried out to assess SARS-CoV-2-specific IgM and IgG antibodies in 119 medical workers recovered after COVID-19, divided into groups based on the disease severity (mild, moderate and asymptomatic), as well as in 62 vaccinated employees, divided into groups according to age. Semi-quantitative measurement of virus-specific antibodies was carried out by ELISA with test systems "SARS-COV-2-IgG-ELISA-BEST" and "SARS-COV-2-IgM-ELISA-BEST".Statistical processing of the research results was carried out using Microsoft Excel 2010 and Statistica 6. Quantitative characteristics were presented as median (ME), lower and upper quartiles (LQ1-UQ3); qualitative parameters – as absolute value and relative number (%). Difference between groups was analyzed by using the χ2 test (qualitative) and the Mann-Whitney U-test (quantitative).Results. The results of the study showed that the majority of employees with a moderate-severe form of SARS-COV-2 had a high level of IgG (PR - a positivity rate of more than 9.0 arbitrary units) 9 months after the disease compared to those who suffered from mild or asymptomatic (83.3% versus 25.8% and 13.3%, p 0.017) infection. The duration of IgG circulation after former illness had no relation to its severity and patient age. The effectiveness of the primary vaccination "Sputnik V" and revaccination with "Sputnik Light" and "KoviVak" was 100% after inoculating the vaccine second component. The lowest level of antibodies after the first vaccination is recorded in persons over 60 years old (1.48 (1.12-3.25 versus PR = 8.48 (5.78-10.11) and 9.27 (5.84-10, 31) arbitrary units, p 0.017)), in comparison with young and middle-age subjects. The speed SARS-COV-2 elimination of IgG at 6, 9 or more months after vaccination depends on relevant initial peak antibody concentration. Subjects who were initially vaccinated with the KoviVac vaccine, IgG was not detected 2 months after vaccination. The protective effect of "Sputnik V", "Sputnik Light", "KoviVac" after re-infection with SARS-COV-2 averages 71.2%. Conclusion. Thus, the results obtained on assessing anti-infectious and post-vaccination immunity against SARS-CoV-2 emphasize the need for further studies on a larger patient cohort, especially in those with asymptomatic infection as well as the elderly subjects.
Relevance. During the ongoing pandemic of a new coronavirus infection (COVID-19), assessment of humoral immunity to vaccinepreventable diseases in healthcare workers is crucial to estimate the risk of healthcare-associated infections. Aim. To assess the humoral immunity to vaccine-preventable diseases: whooping cough, influenza A, viral hepatitis A and B, new coronavirus infection (COVID-19), in healthcare professionals working with infectious patients.Materials and methods. We conducted a cross-sectional study enrolling 252 healthcare workers, which included a survey and assessment of immunoglobulins G to Bordetella pertussis, influenza A virus, hepatitis A virus, HBsAg and HBcAg of hepatitis B virus,
Relevance. It is relevant to study the features of the formation and duration of the humoral immune response to a new coronavirus infection in a high-risk group of infection - among medical workers. Aims. To study the dynamics of the levels of specific antibodies (IgM and IgG) to SARS-CoV2 in unvaccinated MRs of the temporary infectious diseases hospital to assess the trends of the individual humoral immune response to a new coronavirus infection. Materials and methods. We monitored IgM and IgG to SARS-CoV-2 in 68 unvaccinated healthcare workers monthly from July 2020 to July 2021 by two-stage direct solid-phase ELISA using the test systems «SARS-CoV-2-IgG-ELISA-BEST» and «SARS-CoV-2-IgM-ELISA-BEST», Russia. Among them, there were 26.5% men and 73.5% women, the average age was 43.5 ± 1.51 years, doctors 52.9%, paramedical personnel 36.8% and junior staff 10.3%. 69.1% had a history of clinical manifestations of COVID19, among them 42.7% had a mild infection, 20.6% had a moderate infection, and 5.9% had a severe infection, 30.9% were asymptomatic. Statistical processing were carried out using the methods of variation statistics using the Excel statistical package and the WinPepi software product (version 11.65). Results. A decrease in the geometric mean value of IgM titers to SARS-CoV-2 (average monthly decrease of 6.40%) and an increase in the geometric mean value of IgG titers (average monthly increase of 4.26%). An individual assessment of the dynamics of antibodies from the day with the first positive result showed a decrease in the geometric mean values of antibody titers and IgM and IgG to SARS-CoV-2 (monthly average decrease of -23.56% and -1.18%, respectively). An individual assessment of the immune response made it possible to distinguish three groups according to the dynamics of IgM: M0 -IgM in the blood were absent (50 ± 5.7446%); M1 -IgM persisted for 1–2 months, followed by a rapid decrease in titer (16.176 ± 3.7943%); M2 – IgM remained in the blood for three or more months (33.824 ± 5.1033%). By the nature of the dynamics of IgG MR were divided into four troupes. With a downward trend in IgG titer: G0 – IgG does not exceed 95% of the upper confidence limit of the individual trend in any of the samples taken (19.118 ± 4.7686%), G1 – does not exceed 95% of the upper confidence limit of the individual trend starting from 3 months after the start observations (4.412 ± 2.4903%), G2 – there is an excess of 95% of the upper confidence limit of the individual trend starting from 3 months after the start of observation (69.118 ± 5.6027%); G3 – with a trend of increasing IgG titer (7.353 ± 3.1651%). Сonclusions. The results of serological monitoring as a whole indicate the formation of herd immunity in this cohort. Monitoring the intensity of the individual immune response to SARS-CoV-2 throughout the year reflects the natural course of the infectious process and is the basis for vaccination against COVID-19. The results of serological monitoring can be used to predict the epidemiological situation, plan specific and non-specific COVID-19, personalization of vaccination.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.